Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Entera Bio (ENTX) Receivables - Other (2017 - 2018)

Entera Bio has reported Receivables - Other over the past 2 years, most recently at $836000.0 for Q4 2018.

  • For the quarter ending Q4 2018, Receivables - Other rose 359.34% year-over-year to $836000.0, compared with a TTM value of $836000.0 through Dec 2018, up 359.34%, and an annual FY2018 reading of $836000.0, up 359.34% over the prior year.
  • Receivables - Other came in at $836000.0 for Q4 2018, up from $182000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $836000.0 in Q4 2018 to a low of $182000.0 in Q4 2017.